INNOVATE Corp. (VATE) director receives 12,016-share restricted stock grant

Rhea-AI Filing Summary

GFELLER WARREN H reported acquisition or exercise transactions in this Form 4 filing.

INNOVATE Corp. director Warren H. Gfeller received a grant of 12,016 shares of restricted common stock under the company’s Second Amended and Restated 2014 Omnibus Equity Award Plan. The shares vest and become non-forfeitable on the earlier of one year from grant or the next regular annual stockholders’ meeting, subject to continued service. Following this award, he directly holds 79,719 shares of common stock.

Insider Trade Summary

Net Buyer: 12,016 shares

Net Buy 1 txn

Insider GFELLER WARREN H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	12,016	$0.00	$0.00

Holdings After Transaction: Common Stock — 79,719 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).

Key Figures

Restricted shares granted: 12,016 shares Per-share grant price: $0.0000 per share Shares held after transaction: 79,719 shares

3 metrics

Restricted shares granted 12,016 shares Restricted common stock award to director Warren H. Gfeller on 2026-08-11

Per-share grant price $0.0000 per share Reported price for the restricted stock grant, indicating a compensation award

Shares held after transaction 79,719 shares Total direct holdings of common stock by Warren H. Gfeller after the grant

Key Terms

restricted stock, non-forfeitable, Omnibus Equity Award Plan, continued service

4 terms

restricted stock financial

"Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

non-forfeitable financial

"The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary"

Omnibus Equity Award Plan financial

"granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan"

continued service financial

"subject to continued service with the Company through such vesting date"

FAQ

What transaction did INNOVATE Corp. (VATE) director Warren H. Gfeller report?

Warren H. Gfeller reported receiving a grant of 12,016 shares of restricted common stock. The award was made under INNOVATE Corp.’s 2014 Omnibus Equity Award Plan as amended, and it is classified as an acquisition (code A) rather than an open-market purchase.

How many INNOVATE Corp. (VATE) shares does Warren H. Gfeller hold after this grant?

After the restricted stock grant, Warren H. Gfeller directly holds 79,719 shares of INNOVATE Corp. common stock. This figure reflects the newly awarded 12,016 restricted shares in addition to his prior holdings, as reported in the Form 4 filing.

When do Warren H. Gfeller’s new restricted INNOVATE Corp. (VATE) shares vest?

The 12,016 restricted shares vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of stockholders following grant, provided he continues service with the company through that vesting date.

Did Warren H. Gfeller pay a price per share for the INNOVATE Corp. (VATE) restricted stock grant?

No cash price was paid; the reported per-share value is $0.0000, indicating a compensation-related grant. The award represents equity compensation under the company’s omnibus equity award plan rather than a market purchase transaction.

Was the INNOVATE Corp. (VATE) restricted stock grant to Warren H. Gfeller made under a specific plan?

Yes. The 12,016 restricted shares were granted under the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended. This plan governs the terms of equity awards such as restricted stock and their vesting conditions.

Is Warren H. Gfeller’s INNOVATE Corp. (VATE) restricted stock grant contingent on continued service?

Yes. The footnote states the restricted shares vest and become non-forfeitable only if he maintains continued service with INNOVATE Corp. through the vesting date, linking the equity award to ongoing board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 04:13 PM Accepted by SEC EDGAR 08/13/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GFELLER WARREN H

(Last) (First) (Middle)

C/O INNOVATE CORP.

295 MADISON AVENUE, 12TH FL

(Street)

NEW YORK FLORIDA 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INNOVATE Corp. [ VATE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		A(1)		12,016	A	$0	79,719	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). The shares will vest and become non-forfeitable on the earlier of (i) the first anniversary of the grant date and (ii) the first regular annual meeting of the Company's stockholders that occurs following the date of grant (subject to continued service with the Company through such vesting date).

Remarks:

	/s/ Warren H. Gfeller	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)